Climb Bio, Inc.
Company Stats
- Market Cap
- $658.8M
- as of Sep 30, 2026
- Shares Outstanding
- 57.4M
- Free Float
- 53.8%
Income Statement
- Operating Income
- -$67.9M
- Net Income
- -$59.9M
- EBITDA
- -$67.8M
Cash Flow
- Free Cash Flow
- -$54.5M
- FCF Yield
- -8.3%
- Owner FCF Yield
- -9.5%
Balance Sheet
- Cash & Equivalents
- $35.7M
Returns & Capital
- SBC, 3Y Avg
- $8.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$54.5M | — |
| FY2024 | — | -$15.6M | — |
| FY2023 | — | -$20.6M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges